-
Website: https://multiplylabs.com/
-
Email: [email protected]
Multiply Labs specializes in robotic systems for the manufacturing of precision medicines, particularly in cell therapy. Their technology integrates with GMP instruments, offering modular flexibility and high-throughput capabilities. The systems are designed for industrial-scale production of gene-modified cell therapies, ensuring compliance with regulatory standards while optimizing efficiency in biomanufacturing processes.
RSF defines a common language for robot service capability, lifecycle operations, certification pathways, and service-provider networks.
A balanced analysis of the robot intelligence revolution: multi-vendor digital twin platforms (NVIDIA, Siemens, Dassault, ABB, Rockwell, Hexagon), Physical AI VLA models (RT-2, pi0, GR00T N1, AgiBot), current Physical AI limitations, LLM robot programming, and the OEM readiness matrix across US, European, and Chinese manufacturers.
BySimon Dicky Jun 11, 2026From rotary joints hitting 530 N·m+ to linear joints with planetary roller screws, integrated actuators are replacing the three-part drivetrain. Full supplier map: Tihu, PhyArc, RobStride, Schaeffler, maxon — and China's path from 1,000-RMB modules to global standard-setter.
BySimon Dicky May 25, 2026From clinical diagnostics to self-driving labs: a deep analysis of laboratory robotics technologies, mass-production maturity timelines across 12 vertical sectors, 26 key companies, and the investment landscape shaping lab automation through 2030.
BySarah Bakery Apr 05, 2026An evidence-based deep dive into the crop monitoring and aerial scouting segment of agricultural robotics. Covers the market opportunity (ex-China) across North America, EU, Japan, and Israel; key players including Taranis, BASF xarvio, and DJI; emerging technologies such as edge AI, hyperspectral imaging, and satellite–drone fusion; and the structural challenges limiting wider adoption — connectivity gaps, false positives, data fragmentation, and small-farm exclusion.
BySarah Bakery Mar 19, 2026A new RoboMME benchmark study reveals that modern robot AI still struggles with memory — an emerging bottleneck for generalist and humanoid robotics.
ByRobotToday Reporter Mar 17, 2026How OpenClaw's AI agent orchestration exposes which humanoid robotics companies have genuine hardware innovation vs. expensive commodity robots with proprietary software.
BySarah Bakery Feb 19, 2026Robotics hiring in 2026 is driven by deployment, integration, and operations—not hype. A structural map of real entry points for engineers.
ByLeona Tang Feb 10, 2026A startup is collaborating with prominent cell therapy companies to revolutionize the manufacturing process within clean rooms by integrating robotics technology. This innovative approach is set to significantly lower production costs by over 70% and enhance output efficiency compared to traditional manufacturing systems. The initiative aims to address the growing demand for cell therapies, which require precise and sterile environments for production. By leveraging advanced robotics, the startup is not only streamlining operations but also positioning itself as a key player in the rapidly evolving biotechnology sector. This development is particularly timely, as the industry seeks to meet increasing patient needs while maintaining high-quality standards in cell therapy manufacturing.
NvidiaNews Jan 12, 2026Mimic Robotics combines dexterous robotic hands with foundation-model Physical AI to automate human-like manipulation tasks in industry with scalable learning.
ByRobotToday Reporter Nov 23, 2025A look at the leading candidates — such as Apptronik, Figure AI, and Agility Robotics — poised to supply humanoid robots for Foxconn’s Texas AI server plant powered by NVIDIA.
ByThomas Siew Nov 08, 2025Leju Robot rebrands as Leju Intelligence, signaling a strategic shift toward scalable humanoid robotics and a clearer IPO-focused business structure.
ByRobotToday Reporter Oct 25, 2025
Leave a comment